MY188046A - Antiviral activity of baicalein against japanese encephalitis virus - Google Patents
Antiviral activity of baicalein against japanese encephalitis virusInfo
- Publication number
- MY188046A MY188046A MYPI2013000889A MYPI2013000889A MY188046A MY 188046 A MY188046 A MY 188046A MY PI2013000889 A MYPI2013000889 A MY PI2013000889A MY PI2013000889 A MYPI2013000889 A MY PI2013000889A MY 188046 A MY188046 A MY 188046A
- Authority
- MY
- Malaysia
- Prior art keywords
- baicalein
- jev
- japanese encephalitis
- antiviral activity
- encephalitis virus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
The present invention provides an antiviral medicament for treating Japanese Encephalitis Virus (JEV) infection comprises a natural flavonoid compound namely baicalein. In the present invention, antiviral activity of baicalein was evaluated against JEV replication in African green monkey kidney cell line (Vero). Anti-JEV activities of baicalein were examined at different stages of JEV replication cycle. The effects of baicalein on virus replication were determined from Foci Forming Unit Reduction Assay (FFURA) and quantitative RT-PCR.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI2013000889A MY188046A (en) | 2013-03-15 | 2013-03-15 | Antiviral activity of baicalein against japanese encephalitis virus |
PCT/MY2014/000031 WO2014142644A1 (en) | 2013-03-15 | 2014-03-13 | Antiviral activity of baicalein against japanese encephalitis virus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI2013000889A MY188046A (en) | 2013-03-15 | 2013-03-15 | Antiviral activity of baicalein against japanese encephalitis virus |
Publications (1)
Publication Number | Publication Date |
---|---|
MY188046A true MY188046A (en) | 2021-11-12 |
Family
ID=51537156
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI2013000889A MY188046A (en) | 2013-03-15 | 2013-03-15 | Antiviral activity of baicalein against japanese encephalitis virus |
Country Status (2)
Country | Link |
---|---|
MY (1) | MY188046A (en) |
WO (1) | WO2014142644A1 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH072826A (en) * | 1992-03-12 | 1995-01-06 | Sanwa Kagaku Kenkyusho Co Ltd | Flavone derivative |
CA2798209A1 (en) * | 2010-04-23 | 2011-10-27 | Kineta, Inc. | Anti-viral compounds |
MY151083A (en) * | 2012-03-30 | 2014-04-04 | Univ Malaya | Antiviral composition against flavivirus |
-
2013
- 2013-03-15 MY MYPI2013000889A patent/MY188046A/en unknown
-
2014
- 2014-03-13 WO PCT/MY2014/000031 patent/WO2014142644A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2014142644A1 (en) | 2014-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2016000805A1 (en) | Substituted nucleosides, nucleotides and analogs thereof. | |
CL2014000777A1 (en) | Treatment method for hcv comprising at least two direct-acting antiviral agents (daas) and ribavirin, which does not include interferon. | |
CL2014000778A1 (en) | Method of treatment for hcv comprising at least two direct-acting antiviral agents (daas), which does not include interferon or ribavirin. | |
CL2016000952A1 (en) | Carboxamide derivatives and their use as medicines for the treatment of hepatitis b | |
PH12015502261A1 (en) | Macrocyclic deaza-purinones for the treatment of viral infections | |
MX2018008346A (en) | Oncolytic virus and checkpoint inhibitor combination therapy. | |
PH12015500073A1 (en) | Macrocyclic purines for the treatment of viral infections | |
MY174018A (en) | Heterocyclic derivates | |
NZ746139A (en) | Methods for treating conditions associated with masp-2 dependent complement activation | |
PH12017501958A1 (en) | Rsv antiviral pyrazolo- and triazolo-pyrimidine compounds | |
MX2016004492A (en) | Inhibitors of human immunodeficiency virus replication. | |
MX363726B (en) | miRNA-124 AS A BIOMARKER. | |
MX2017005350A (en) | Therapy for inhibition of single-stranded rna virus replication. | |
BR112017026061A2 (en) | compound, use of a compound, and method of treating a viral infection | |
EP3212658A4 (en) | 2',2'-dihalo nucleoside analogs for treatment of the flaviviridae family of viruses and cancer | |
PH12016500465A1 (en) | Deoxynojirimycin derivatives and methods of their using | |
CL2018001804A1 (en) | Use of carrimicin in resistant mycobacterium tuberculosis infection | |
MY177473A (en) | Agent for elevating nitric oxide concentration | |
PH12020550673A1 (en) | Pyrazolopyrimidines having activity against the respiratory syncytial virus (rsv) | |
MY188046A (en) | Antiviral activity of baicalein against japanese encephalitis virus | |
MX356102B (en) | Compounds and methods for treating leukemia. | |
NZ717880A (en) | Glucopyranosyl-substituted indole-urea derivatives and their use as sglt inhibitors | |
PH12018502320A1 (en) | Reagents for treatment of hepatitis b virus (hbv) infection and use thereof | |
BR112014026158A2 (en) | methods and compositions for the treatment of viral infections | |
WO2014121170A3 (en) | Antiviral compounds |